Resolution of Recalcitrant Uveitic Optic Disc Edema Following Administration of Methotrexate: Two Case Reports

A 13-year-old male and a 15-year-old female presented with optic disc edema associated with chronic recurrent uveitis. While the ocular inflammation responded to high doses of oral prednisolone, the disc edema showed little improvement. After oral administration of methotrexate, the disc edema and ocular inflammation were resolved, and the dose of oral corticosteroid could be reduced.

[1]  G. Rebolleda,et al.  Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. , 2009, Investigative ophthalmology & visual science.

[2]  J. Kempen,et al.  Methotrexate for ocular inflammatory diseases. , 2009, Ophthalmology.

[3]  F. Yu,et al.  Chronic anterior uveitis in children: clinical characteristics and complications. , 2009, American journal of ophthalmology.

[4]  W. Freeman,et al.  Bilateral papillitis associated with bilateral anterior uveitis in a child. , 2007, Journal of pediatric ophthalmology and strabismus.

[5]  S. Schmidt,et al.  Visual field changes in methotrexate therapy. Case report and review of the literature. , 2006, Le Journal medical libanais. The Lebanese medical journal.

[6]  C. Pavesio,et al.  The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. , 2006, The British journal of ophthalmology.

[7]  B. Monheit,et al.  Optic disk edema associated with sudden-onset anterior uveitis. , 2005, American journal of ophthalmology-glaucoma.

[8]  G. Clare,et al.  Reversible optic neuropathy associated with low-dose methotrexate therapy. , 2005, Journal of neuro-ophthalmology.

[9]  I. Foeldvari,et al.  Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. , 2005, The Journal of rheumatology.

[10]  M. A. van de Laar,et al.  Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[11]  P. McCluskey,et al.  Methotrexate‐induced optic neuropathy , 2002, Clinical & experimental ophthalmology.

[12]  H. Blom,et al.  Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. , 1998, Seminars in arthritis and rheumatism.

[13]  T. Mimori,et al.  [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis]. , 1997, Ryumachi. [Rheumatism].

[14]  F. Salaffi,et al.  Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: Report of five cases and review of the literature , 1997, Clinical Rheumatology.

[15]  Randall G. Lee,et al.  Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis. , 1993, Arthritis and rheumatism.

[16]  J. Doroshow,et al.  Ocular irritation from high‐dose methotrexate therapy: Pharmacokinetics of drug in the tear film , 1981, Cancer.

[17]  B. Johansson.  Visual field defects during low-dose methotrexate therapy , 2004, Documenta Ophthalmologica.